What additional tumor marker is commonly used in follow-up?
Carcinoembryonic antigen (CEA).
Follow-up oral questions and concise, clinically defensible model answers. Your MCQ remains open in its original tab.
← Return to original MCQCarcinoembryonic antigen (CEA).
MEN2 due to activating germline RET variants.
Within the thyroid parenchyma, typically between or at the periphery of follicles, rather than lining colloid-filled follicular lumina.